NE 52-QQ57 is a selective, and orally available antagonist of G-protein coupled receptor 4 (GPR4) with IC50 of 0.07 μM. NE 52-QQ57 effectively blocks GPR4-mediated cAMP accumulation with IC50 of 26.8 nM in HEK293 cells. The antagonism of GPR4 with NE 52-QQ57 significantly inhibits the AGE-induced increased expression of several key inflammatory cytokines and signaling molecules, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, inducible nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase 2 (COX2), and prostaglandin E2 (PGE2).
[1] Juraj Velcicky, et al. J Med Chem. 2017 May 11;60(9):3672-3683. [2] P S Hosford, et al. Neuropharmacology. 2018 Aug;138:381-392. [3] Haochuan Liu, et al. Chem Res Toxicol. 2020 Jul 20;33(7):1915-1921.
















